1 |
Koo, J.S., Seo, B.l., Park, J.H., Roh, S.S. Analysis of papers on Oriental herbal medicines(prescriptions and herbs) for dementia. Kor. J. Herbology. 25(3):131-137, 2010.
|
2 |
Kim, S.T., Kang, H.W., Han, P.L., Cho, H.K., Kim, T.H., Lyu, Y.S., Son, H.J. Effects of Antidementia on LMK02 in APP-transgenic Fly. J. of Oriental Neuropsychiatry. 19(2):151-163. 2008.
|
3 |
Kim, T.Y., Kim, C.J., Oh, J.W. The current status about Alzheimer’s dementia in the journal of oriental neuropsychiatry for evidence based medicine. J of Oriental neuropsychiatry. 25(3):287-296, 2014.
DOI
|
4 |
Perry, E.K., Peryy, P.H., Blessed, G., Tomlinson, B.E. Necropsy evidence of central cholinergic deficts in senile dementia. Lancet. 1: 8004-8189, 1997.
|
5 |
Browen, D.M., Benton, J.S., Spillane, J.A., Smith, C.C., Allen, S.J. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J. Neurol. Sci. 57: 191-202, 1982.
DOI
|
6 |
Schroder, H., Giacobini, E., Struble, R.G., Luiten, P.G., Zilles, K., Strosberg, A.D. Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer’s disease. Brain Res. Bull. 27: 631-636, 1991.
DOI
|
7 |
Polinsky, R.J. Clinical pharmacology of rivastigmine: A new generation acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease. Clin. Ther. 20: 634-647, 1998.
DOI
|
8 |
Kwak, J.H., Jeong, C.H., Kim, J.H., Choi, G.N., Shin, Y.H., Lee, S.C., Cho, S.H., Choi, S.G., Heo, H.J. Acetylcholinesterase inhibitory effect of green tea extracts according to storage condition. Korean J. Food Sci. Technol. 41(4):435-440, 2009.
|
9 |
Fu, H., Dou, J., Li, W., Cui, W., Mak, S., Hu, Q., Luo, J., Lam, C.S., Pang, Y., Youdim, M.B. and Han, Y. Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently. Eur. J. Pharmacol. 623(1-3):14-21, 2009.
DOI
|
10 |
Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon, A., Song, Y.Q., Rogaeva, E., Chen, F., Kawarai, T., Supala, A., Levesque, L., Yu, H., Yang, D.S., Holmes, E., Milman, P., Liang, Y., Zhang, D.M., Xu, D.H., Sato, C., Rogaev, E., Smith, M., Janus, C., Zhang, Y., Aebersold, R.,Farrer, L.S., Sorbi, S., Bruni, A., Fraser, P., St. George-Hyslop, P. Nicastrin modulates presenilin-mediatednotch/glp-1 signal transduction and betaAPP processing. Nature 407: 48-54, 2000.
DOI
|
11 |
Lee, S.F., Shah, S., Li, H., Yu, C., Han, W., Yu, G Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-beta precursor protein and Notch. J. Biol. Chem. 277: 45013-45019, 2002.
DOI
|
12 |
Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. and Haass, C. PEN-2 is an integral component of the γ-secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol.Chem. 277: 39062-39061, 2002.
DOI
|
13 |
Robert, V., Brian, D. Bennett and Safura babu-Khan. β-secretase cleavage of Alzheimer's precursor protein by the transmembraneaspartic protease BACE. Science. 22: 735-741, 1999.
|
14 |
Yan, R., Vassar, R. Targeting the β secretase BACE1 for Alzheimer's disease therapy. Lancet Neurol. 13(3):319-329, 2014.
DOI
|
15 |
Lee, H.J., Lee, D.Y., Noh, Y.H., Yun, J.Y., Chung, Y.H., Kim, S.S., Lee, W.B. Protective Effect of Green Tea Extract on Neuronal Cell Death in Alzheimer Model using β-amyloid Peptide. The Korean J. Anat. 38(6):543-552, 2005.
|
16 |
Morris, J.C. Classification of dementia and Alzheimer's disease. Acta Neurol. Scand. 165: 41-50, 1996.
DOI
|
17 |
Zhao, L.N., Long, H., Mu, Y., Chew, L.Y. The toxicity of amyloid β oligomers. Int J Mol Sci. 13(6):7303-7327, 2012.
DOI
|
18 |
Yang, F., Lim, G.P., Begum, A.N., Ubeda, O.J., Simmons, M.R., Ambegaokar, S.S., Chen, P.P., Kayed, R., Glabe, C.G., Frautschy, S.A., Cole, G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.J Biol Chem. Feb 18;280(7):5892-5901, 2005.
DOI
|
19 |
http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B35001
|
20 |
Iqbal, K., Sisodia, S.S. and Winblad, B. Alzheimer's disease. Advances in etionlogy, pathogenesis and therapeutics. John Wiley & Sons, Ltd. 2001.
|
21 |
Selkoe, D.J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8: 447-453, 1998.
DOI
|
22 |
Strittmatter, W.J., Weisgraber, K.H., Huang, D.Y., Dong, L.M., Salvesen, G.S., Pericak-Vance, M., Schmechel, D., Saunders, A.M., Goldgaber, D. and Roses, A.D. Binding of human apolipoprotein E to synthetic amyloid beta peptide isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. 90: 8098-8102, 1993.
DOI
|
23 |
Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923, 1993.
DOI
|
24 |
Selkoe, D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399: 23-31, 1999.
DOI
|
25 |
Jann, M.W. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy. 20: 1-12, 2000.
DOI
|
26 |
Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, P., Teplow, D.B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M.A., Biere, A.L., Curran, E., Burgess, T., Louis, J.C., Collins, F., Treanor, J., Rogers, G. and Citron, M. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741, 1999.
DOI
|
27 |
Sugimoto, H. Donepezil hydrochloride. a treatment drug for Alzheimer's disease. Chem. Rec. 1: 63-73, 2001.
DOI
|
28 |
Zarotsky, V., Sramek, J.J. and Cutler, N.R. Galantamine hydrobromide. an agent for Alzheimer's disease. Am. J. Health Syst. Pharm. 60: 446-452, 2003.
|
29 |
Colin K., Combs, Derrick E. Johnson, J. Colleen Karlo, Steven B. Canndy and Gary E. Landreth. Inflammatory mechanisms in Alzheimer's Disease: Inhibition ofβ-Amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ Agonists. The journal of Neuroscience. 20(2):558-567, 2000.
|
30 |
Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A.L., Citron, M., Landreth, G. Anti-inflammatory drug therapy alters β-amyloid processing and deposition in an animal model of Alzheimer's Disease. The journal of Neuroscience. 23(20):7504-7509, 2003.
|
31 |
Kim, E.J., Kim, G.Y. Hypoglycemic and Hypolipidemic Effect of Rosa rugosa Radix in Streptozotocine-induced Diabetic Rats. Korean Journal of Oriental Physiology and Pathology. 24(5):866-871, 2010.
|
32 |
Park, J.H. Medical Plants of Korea. Shinilbooks. 1: 668, 2012.
|